Log in to save to my catalogue

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell in...

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_jitc_2022_004877

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration

About this item

Full title

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration

Publisher

England

Journal title

Journal for immunotherapy of cancer, 2022-12, Vol.10 (12), p.e004877

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

CD103, an integrin specifically expressed on the surface of cancer-reactive T cells, is significantly increased during successful immunotherapy across human malignancies. In this study, we describe the generation and zirconium-89 (
Zr) radiolabeling of monoclonal antibody (mAb) clones that specifically recognize human CD103 for non-invasive immu...

Alternative Titles

Full title

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1136_jitc_2022_004877

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_jitc_2022_004877

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2022-004877

How to access this item